Trypanosomiasis and encephalitis: possible aetiology and treatment.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Transactions of the Royal Society of Tropical Medicine and Hygiene

• Publication date

  1989-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/0035-9203(89)90272-1PMID 2617602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of 2-substituted 5-nitroimidazoles in the treatment of chronic murineTrypanosoma brucei infections with central nervous system involvement

  2004cited by this paper
• Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.

  1987cited by this paper
• Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy.

  1986cited by this paper
• Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.

  1983cited by this paper
• Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.

  1983cited by this paper

• In Vitro and In Vivo Evaluation of 28DAP010, a Novel Diamidine for Treatment of Second-Stage African Sleeping Sickness

  2014cites this paper
• Sickness of Second-Stage African Sleeping Treatment 28DAP010, a Novel Diamidine for Evaluation of In Vivo and In Vitro

  2014cites this paper
• Animal Models for Tropical Parasitic Diseases

  2013cites this paper
• Biological and pharmacological investigations of novel diamidines in animal models of human African trypanosomiasis

  2013cites this paper
• Melarsoprol cyclodextrin inclusion complexes for the treatment for human African trypanosomiasis

  2011influential citation
• Magnetic Resonance Imaging to Assess Blood–Brain Barrier Damage in Murine Trypanosomiasis

  2011cites this paper
• Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis

  2011influential citation
• Human African trypanosomiasis, chemotherapy and CNS disease.

  2009cites this paper
• Efficacy of the Novel Diamidine Compound 2,5-Bis(4-Amidinophenyl)-Furan-Bis- O -Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense Infection in Vervet Monkeys after Oral Administration (cid:1)

  2009cites this paper
• Efficacy of the Novel Diamidine Compound 2,5-Bis(4-Amidinophenyl)- Furan-Bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense Infection in Vervet Monkeys after Oral Administration

  2008cites this paper
• LA TRIPANOSOMOSI HUMANA AFRICANA AL FOCUS HISTÒRIC DE QUIÇAMA, ANGOLA

  2005cites this paper
• AFRICAN TRYPANOSOME INTERACTIONS WITH AN IN VITRO MODEL OF THE HUMAN BLOOD–BRAIN BARRIER

  2004cites this paper
• Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.

  2002cites this paper
• Present strategies in the treatment of human African trypanosomiasis

  1999cites this paper
• Animal Models of CNS (second-stage) Sleeping Sickness

  1999cites this paper
• The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis

  1997cites this paper
• Post-treatment hind-leg paralysis in mice infected with Trypanosoma brucei brucei: a light microscopic study.

  1997cites this paper
• Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.

  1995cites this paper
• Successful treatment of experimental murine Trypanosoma brucei infection with topical melarsoprol gel.

  1995cites this paper
• The treatment of human African trypanosomiasis.

  1994cites this paper
• Combination chemotherapy of CNS trypanosomiasis.

  1993cites this paper
• Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies.

  1993cites this paper
• The use of azathioprine to ameliorate post‐treatment encephalopathy associated with African trypanosomiasis

  1992cites this paper
• Correlation of autoantibody titres with central nervous system pathology in experimental African trypanosomiasis.

  1992cites this paper
• African trypanosomiasis: more aggressive treatment or more aggressive research?

  1992cites this paper
• Chapter 3 – Trypanosomes Causing Disease in Man in Africa

  1992cites this paper
• [Cerebral trypanosomiasis: epidemiology, clinical aspects, therapy and illness course].

  1992cites this paper
• African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis.

  1991cites this paper
• Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice

  1991cites this paper
• Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.

  1991cites this paper
• Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis.

  1990cites this paper
• [East African sleeping sickness (Trypanosoma rhodesiense infection) in 2 Swiss travelers to the tropics].

  1990cites this paper
• Parasitic Disease in Clinical Practice

  1990cites this paper
• Some Parasitoses Involving the Central Nervous System

  1990cites this paper